EuBiologics Co (XKRX:206650) Net Change in Cash : ₩12,957 Mil (TTM As of Dec. 2024)

View and export this data going back to 2017. Start your Free Trial

What is EuBiologics Co Net Change in Cash?

Net Change in Cash is calculated as the total of Cash Flow from Operations , Cash Flow from Investing, Cash Flow from Financing, and Effect of Exchange Rate Changes.

EuBiologics Co's Net Change in Cash for the three months ended in Dec. 2024 was ₩10,955 Mil. Its Net Change in Cash for the trailing twelve months (TTM) ended in Dec. 2024 was ₩12,957 Mil.

EuBiologics Co Net Change in Cash Historical Data

The historical data trend for EuBiologics Co's Net Change in Cash can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

EuBiologics Co Net Change in Cash Chart

EuBiologics Co Annual Data

Trend

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Dec24

Net Change in Cash

Get a 7-Day Free Trial

47,420.78

-46,553.54

4,509.39

-1,146.85

12,956.99

EuBiologics Co Quarterly Data
	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24	Dec24
Net Change in Cash	Get a 7-Day Free Trial															1,915.82	4,565.86	-5,470.69	2,907.18	10,954.64

EuBiologics Co Net Change in Cash Calculation

EuBiologics Co's Net Change in Cash for the fiscal year that ended in Dec. 2024 is calculated as

Net Change in Cash	=	Cash Flow from Operations	+	Cash Flow from Investing	+	Cash Flow from Financing	+	Effect of Exchange Rate Changes
	=	43211.898	+	-26997.683	+	-3811.18	+	553.951
	=	12,957

EuBiologics Co's Net Change in Cash for the quarter that ended in Dec. 2024

Net Change in Cash = Cash Flow from Operations + Cash Flow from Investing + Cash Flow from Financing + Effect of Exchange Rate Changes

= 30753.694 + -17411.048 + -3118.386 + 730.378

= 10,955

Net Change in Cash for the trailing twelve months (TTM) ended in Dec. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was ₩12,957 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

EuBiologics Co Net Change in Cash Related Terms
Thank you for viewing the detailed overview of EuBiologics Co's Net Change in Cash provided by GuruFocus.com. Please click on the following links to see related term pages.

EuBiologics Co Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » EuBiologics Co Ltd (XKRX:206650) » Definitions » Net Change in Cash

Comparable Companies

XKRX:041960 XKRX:220100 XKRX:170900 XKRX:200670 XKRX:019170 XKRX:001060 XKRX:003520 XKRX:058820 XKRX:102940 XKRX:082800 ZTS XTER:MRK NSE:SUNPHARMA TSE:4502 LSE:HLN XSWX:GALD NSE:DIVISLAB HKSE:03692 XSWX:SDZ XTAE:TEVA

Traded in Other Exchanges

N/A

Address

6F Bomnal-A-Chim B/D Mabang-ro 8, Seocho-gu, Seoul, KOR, 06778

Website

http://www.eubiologics.com

EuBiologics Co Ltd is a biopharmaceutical company, which develops and supplies vaccines for epidemics and antibiotic resistance in South Korea. It offers Euvchol, an oral cholera prevention vaccine; and CRM197, a diphtheria toxin mutant vaccine, Inaba Cairo, and among others.

EuBiologics Co Headlines

No Headlines